SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-014449
Filing Date
2009-03-05
Accepted
2009-03-05 09:15:22
Documents
7
Period of Report
2009-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-6907_18k.htm 8-K 33140
2 EX-4.1 a09-6907_1ex4d1.htm EX-4.1 86041
3 EX-5.1 a09-6907_1ex5d1.htm EX-5.1 11578
4 EX-99.1 a09-6907_1ex99d1.htm EX-99.1 109582
5 EX-99.2 a09-6907_1ex99d2.htm EX-99.2 118839
6 EX-99.3 a09-6907_1ex99d3.htm EX-99.3 7851
7 GRAPHIC g69071kei001.jpg GRAPHIC 2798
  Complete submission text file 0001104659-09-014449.txt   372560
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 09657410
SIC: 2834 Pharmaceutical Preparations